+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

PRINTER FRIENDLY

Genito-Urinary Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery

  • ID: 5028667
  • Report
  • May 2020
  • Region: Global
  • 300 pages
  • The Business Research Company
1 of 5

Enquire about COVID-19 updates for this product.

Enquire Now

FEATURED COMPANIES

  • Allergan Plc
  • Astellas Pharma Inc
  • Bayer AG
  • Daiichi Sankyo Company
  • Pfizer Inc
  • MORE
Genito-Urinary Drugs Global Market Report 2020-30: COVID-19 Impact and Recovery from the publisher provides the strategists, marketers and senior management with the critical information they need to assess the global genito-urinary drugs market as it emerges from the COVID-19 shut down.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market is being affected by the coronavirus and how it is likely to emerge and grow as the impact of the virus abates.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market research findings.
  • Benchmark performance against key competitors.
  • Utilize the relationships between key data sets for superior strategizing.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3 working days of order.
Description:
Where is the largest and fastest growing market for the genito-urinary drugs? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The Genito-Urinary Drugs market global report from the publisher answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography. It places the market within the context of the wider genito-urinary drugs market, and compares it with other markets.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, the impact of the COVID-19 virus and forecasting its recovery.
  • Market segmentations break down market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the impact and recovery trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • Competitive landscape gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
  • The genito-urinary drugs market section of the report gives context. It compares the genito-urinary drugs market with other segments of the pharmaceutical drugs market by size and growth, historic and forecast. It analyses GDP proportion, expenditure per capita, genito-urinary drugs indicators comparison.
Scope

Markets Covered:
1) By Type: Hormonal Contraceptives; Drugs For Benign Prostatic hypertrophy; Drugs For Infertility; Drugs For Erectile Dysfunction; Drugs For Urinary Incontinence And Overactive Bladder; Drugs For Infections And Others; Drugs For Hormonal Replacement Therapy; Diuretics
2) By Distribution Channel: Hospital Pharmacies; Retail Pharmacies/ Drug Stores; Others
3) By Route Of Administration: Oral; Parenteral; Others
4) By Drug Classification: Branded Drugs; Generic Drugs
5) By Mode Of Purchase: Prescription-Based Drugs; Over-The-Counter Drugs

Companies Mentioned: Daiichi Sankyo Company; Pfizer Inc; Bayer AG; Astellas Pharma Inc; Allergan Plc

Metrics Covered: Number of Enterprises; Number of Employees

Countries: Argentina; Australia; Austria; Belgium; Brazil; Canada; Chile; China; Colombia; Czech Republic; Denmark; Egypt; Finland; France; Germany; Hong Kong; India; Indonesia; Ireland; Israel; Italy; Japan; Malaysia; Mexico; Netherlands; New Zealand; Nigeria; Norway; Peru; Philippines; Poland; Portugal; Romania; Russia; Saudi Arabia; Singapore; South Africa; South Korea; Spain; Sweden; Switzerland; Thailand; Turkey; UAE; UK; USA; Venezuela; Vietnam

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita, genito-urinary drugs indicators comparison.

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

This report will be delivered within 1-3 business days.
Note: Product cover images may vary from those shown
2 of 5

FEATURED COMPANIES

  • Allergan Plc
  • Astellas Pharma Inc
  • Bayer AG
  • Daiichi Sankyo Company
  • Pfizer Inc
  • MORE
1. Executive Summary

2. Report Structure

3. Genito-Urinary Drugs Market Characteristics
3.1. Market Definition
3.2. Key Segmentations

4. Genito-Urinary Drugs Market Product Analysis
4.1. Leading Products/ Services
4.2. Key Features and Differentiators
4.3. Development Products

5. Genito-Urinary Drugs Market Supply Chain
5.1. Supply Chain
5.2. Distribution
5.3. End Customers

6. Genito-Urinary Drugs Market Customer Information
6.1. Customer Preferences
6.2. End Use Market Size and Growth

7. Genito-Urinary Drugs Market Trends And Strategies

8. Genito-Urinary Drugs Market Size And Growth
8.1. Market Size
8.2. Historic Market Growth, Value ($ Billion)
8.2.1. Drivers Of The Market
8.2.2. Restraints On The Market
8.3. Forecast Market Growth, Value ($ Billion)
8.3.1. Drivers Of The Market
8.3.2. Restraints On The Market

9. Genito-Urinary Drugs Market Regional Analysis
9.1. Global Genito-Urinary Drugs Market, 2019, By Region, Value ($ Billion)
9.2. Global Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
9.3. Global Genito-Urinary Drugs Market, Growth And Market Share Comparison, By Region

10. Genito-Urinary Drugs Market Segmentation
10.1. Global Genito-Urinary Drugs Market, Segmentation By Type, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hormonal Contraceptives
  • Drugs For Benign Prostatic hypertrophy
  • Drugs For Infertility
  • Drugs For Erectile Dysfunction
  • Drugs For Urinary Incontinence And Overactive Bladder
  • Drugs For Infections And Others
  • Drugs For Hormonal Replacement Therapy
  • Diuretics
10.2. Global Genito-Urinary Drugs Market, Segmentation By Distribution Channel, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Hospital Pharmacies
  • Retail Pharmacies/ Drug Stores
  • Others
10.3. Global Genito-Urinary Drugs Market, Segmentation By Route Of Administration, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Oral
  • Parenteral
  • Others
10.4. Global Genito-Urinary Drugs Market, Segmentation By Drug Classification, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Branded Drugs
  • Generic Drugs
10.5. Global Genito-Urinary Drugs Market, Segmentation By Mode Of Purchase, Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F, $ Billion
  • Prescription-Based Drugs
  • Over-The-Counter Drugs
11. Genito-Urinary Drugs Market Metrics
11.1. Genito-Urinary Drugs Market Size, Percentage Of GDP, 2015-2023, Global
11.2. Per Capita Average Genito-Urinary Drugs Market Expenditure, 2015-2023, Global

12. Asia-Pacific Genito-Urinary Drugs Market
12.1. Asia-Pacific Genito-Urinary Drugs Market Overview
12.2. Asia-Pacific, Genito-Urinary Drugs Market, 2019, By Country, Value ($ Billion)
12.3. Asia-Pacific, Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
12.4. Asia-Pacific, Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
12.5. Asia-Pacific, Genito-Urinary Drugs Market Metrics
12.5.1. Per Capita Average Genito-Urinary Drugs Expenditure, 2015-2023, Asia-Pacific Countries
12.6. Asia-Pacific Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7. Asia-Pacific Genito-Urinary Drugs Market: Country Analysis
12.7.1. China Genito-Urinary Drugs Market
12.7.1.1. China Genito-Urinary Drugs Market Overview
12.7.1.2. China Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.1.3. China Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.2. Australia Genito-Urinary Drugs Market
12.7.2.1. Australia Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.2.2. Australia Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.3. Hong Kong Genito-Urinary Drugs Market
12.7.3.1. Hong Kong Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.4. India Genito-Urinary Drugs Market
12.7.4.1. India Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.4.2. India Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.5. Indonesia Genito-Urinary Drugs Market
12.7.5.1. Indonesia Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.5.2. Indonesia Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.6. Japan Genito-Urinary Drugs Market
12.7.6.1. Japan Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.6.2. Japan Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.7. Malaysia Genito-Urinary Drugs Market
12.7.7.1. Malaysia Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.8. New Zealand Genito-Urinary Drugs Market
12.7.8.1. New Zealand Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.9. Philippines Genito-Urinary Drugs Market
12.7.9.1. Philippines Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.10. Singapore Genito-Urinary Drugs Market
12.7.10.1. Singapore Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.11. South Korea Genito-Urinary Drugs Market
12.7.11.1. South Korea Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.11.2. South Korea Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.12. Thailand Genito-Urinary Drugs Market
12.7.12.1. Thailand Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
12.7.13. Vietnam Genito-Urinary Drugs Market
12.7.13.1. Vietnam Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

13. Western Europe Genito-Urinary Drugs Market
13.1. Western Europe Genito-Urinary Drugs Market Overview
13.2. Western Europe, Genito-Urinary Drugs Market, 2019, By Country, Value ($ Billion)
13.3. Western Europe, Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
13.4. Western Europe, Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
13.5. Western Europe, Genito-Urinary Drugs Market Metrics
13.5.1. Per Capita Average Genito-Urinary Drugs Expenditure, 2015-2023, Western Europe Countries
13.6. Western Europe Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7. Western Europe Genito-Urinary Drugs Market: Country Analysis
13.7.1. Austria Genito-Urinary Drugs Market
13.7.1.1. Austria Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.2. Belgium Genito-Urinary Drugs Market
13.7.2.1. Belgium Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.3. Denmark Genito-Urinary Drugs Market
13.7.3.1. Denmark Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.4. Finland Genito-Urinary Drugs Market
13.7.4.1. Finland Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5. France Genito-Urinary Drugs Market
13.7.5.1. France Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.5.2. France Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6. Germany Genito-Urinary Drugs Market
13.7.6.1. Germany Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.6.2. Germany Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.7. Ireland Genito-Urinary Drugs Market
13.7.7.1. Ireland Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.8. Italy Genito-Urinary Drugs Market
13.7.8.1. Italy Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.9. Netherlands Genito-Urinary Drugs Market
13.7.9.1. Netherlands Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.10. Norway Genito-Urinary Drugs Market
13.7.10.1. Norway Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.11. Portugal Genito-Urinary Drugs Market
13.7.11.1. Portugal Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.12. Spain Genito-Urinary Drugs Market
13.7.12.1. Spain Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.13. Sweden Genito-Urinary Drugs Market
13.7.13.1. Sweden Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.14. Switzerland Genito-Urinary Drugs Market
13.7.14.1. Switzerland Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.15. UK Genito-Urinary Drugs Market
13.7.15.1. UK Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
13.7.15.2. UK Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

14. Eastern Europe Genito-Urinary Drugs Market
14.1. Eastern Europe Genito-Urinary Drugs Market Overview
14.2. Eastern Europe, Genito-Urinary Drugs Market, 2019, By Country, Value ($ Billion)
14.3. Eastern Europe, Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
14.4. Eastern Europe, Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
14.5. Eastern Europe, Genito-Urinary Drugs Market Metrics
14.5.1. Per Capita Average Genito-Urinary Drugs Expenditure, 2015-2023, Eastern Europe Countries
14.6. Eastern Europe Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7. Eastern Europe Genito-Urinary Drugs Market: Country Analysis
14.7.1. Czech Republic Genito-Urinary Drugs Market,
14.7.1.1. Czech Republic Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.2. Poland Genito-Urinary Drugs Market
14.7.2.1. Poland Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.3. Romania Genito-Urinary Drugs Market
14.7.3.1. Romania Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.4. Russia Genito-Urinary Drugs Market
14.7.4.1. Russia Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
14.7.4.2. Russia Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

15. North America Genito-Urinary Drugs Market
15.1. North America Genito-Urinary Drugs Market Overview
15.2. North America, Genito-Urinary Drugs Market, 2019, By Country, Value ($ Billion)
15.3. North America, Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
15.4. North America, Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
15.5. North America, Genito-Urinary Drugs Market Metrics
15.5.1. Per Capita Average Genito-Urinary Drugs Expenditure, 2015-2023, North America Countries
15.6. North America Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7. North America Genito-Urinary Drugs Market: Country Analysis
15.7.1. Canada Genito-Urinary Drugs Market
15.7.1.1. Canada Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.2. Mexico Genito-Urinary Drugs Market
15.7.2.1. Mexico Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.3. USA Genito-Urinary Drugs Market
15.7.3.1. USA Genito-Urinary Drugs Market Overview
15.7.3.2. USA Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
15.7.3.3. USA Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

16. South America Genito-Urinary Drugs Market
16.1. South America Genito-Urinary Drugs Market Overview
16.2. South America, Genito-Urinary Drugs Market, 2019, By Country, Value ($ Billion)
16.3. South America, Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
16.4. South America, Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
16.5. South America, Genito-Urinary Drugs Market Metrics
16.5.1. Per Capita Average Genito-Urinary Drugs Expenditure, 2015-2023, South America Countries
16.6. South America Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7. South America Genito-Urinary Drugs Market: Country Analysis
16.7.1. Argentina Genito-Urinary Drugs Market
16.7.1.1. Argentina Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.2. Brazil Genito-Urinary Drugs Market
16.7.1.1. Brazil Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.2.2. Brazil Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.3. Chile Genito-Urinary Drugs Market
16.7.3.1. Chile Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.4. Colombia Genito-Urinary Drugs Market
16.7.4.1. Colombia Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.5. Peru Genito-Urinary Drugs Market
16.7.5.1. Peru Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
16.7.6. Venezuela Genito-Urinary Drugs Market
16.7.6.1. Venezuela Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

17. Middle East Genito-Urinary Drugs Market
17.1. Middle East Genito-Urinary Drugs Market Overview
17.2. Middle East, Genito-Urinary Drugs Market, 2019, By Country, Value ($ Billion)
17.3. Middle East, Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
17.4. Middle East, Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
17.5. Middle East, Genito-Urinary Drugs Market Metrics
17.5.1. Per Capita Average Genito-Urinary Drugs Expenditure, 2015-2023, Middle East Countries
17.6. Middle East Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7. Middle East Genito-Urinary Drugs Market: Country Analysis
17.7.1. Saudi Arabia Genito-Urinary Drugs Market
17.7.1.1. Saudi Arabia Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.2. Israel Genito-Urinary Drugs Market
17.7.2.1. Israel Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.3. Turkey Genito-Urinary Drugs Market
17.7.3.1. Turkey Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
17.7.4. UAE Genito-Urinary Drugs Market
17.7.4.1. UAE Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

18. Africa Genito-Urinary Drugs Market
18.1. Africa Genito-Urinary Drugs Market Overview
18.2. Africa, Genito-Urinary Drugs Market, 2019, By Country, Value ($ Billion)
18.3. Africa, Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Country
18.4. Africa, Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Growth And Market Share Comparison, By Country
18.5. Africa, Genito-Urinary Drugs Market Metrics
18.5.1. Per Capita Average Genito-Urinary Drugs Expenditure, 2015-2023, Africa Countries
18.6. Africa Genito-Urinary Drugs Market, Segmentation By Type, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7. Africa Genito-Urinary Drugs Market: Country Analysis
18.7.1. Egypt Genito-Urinary Drugs Market
18.7.1.1. Egypt Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.2. Nigeria Genito-Urinary Drugs Market
18.7.2.1. Nigeria Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)
18.7.3. South Africa Genito-Urinary Drugs Market
18.7.3.1. South Africa Genito-Urinary Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Value ($ Billion)

19. Genito-Urinary Drugs Market Competitive Landscape
19.1. Competitive Market Overview
19.2. Market Shares
19.3. Company Profiles
19.3.1. Daiichi Sankyo Company
19.3.1.1. Company Overview
19.3.1.2. Products And Services
19.3.1.3. Strategy
19.3.1.4. Financial Performance
19.3.2. Pfizer Inc
19.3.2.1. Company Overview
19.3.2.2. Products And Services
19.3.2.3. Strategy
19.3.2.4. Financial Performance
19.3.3. Bayer AG
19.3.3.1. Company Overview
19.3.3.2. Products And Services
19.3.3.3. Strategy
19.3.3.4. Financial Performance
19.3.4. Astellas Pharma Inc
19.3.4.1. Company Overview
19.3.4.2. Products And Services
19.3.4.3. Strategy
19.3.4.4. Financial Performance
19.3.5. Allergan Plc
19.3.5.1. Company Overview
19.3.5.2. Products And Services
19.3.5.3. Strategy
19.3.5.4. Financial Performance

20. Key Mergers And Acquisitions In The Genito-Urinary Drugs Market

21. Market Background: Pharmaceutical Drugs Market
21.1. Pharmaceutical Drugs Market Characteristics
21.2. Pharmaceutical Drugs Market Historic and Forecast, 2015-2019, 2023F, 2025F, 2030F Growth, By Segment, Value ($ Billion), Global
21.3. Global Pharmaceutical Drugs Market, 2019, By Region, Value ($ Billion)
21.4. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Historic And Forecast, By Region
21.5. Global Pharmaceutical Drugs Market, 2015-2019, 2023F, 2025F, 2030F, Segmentation By Type, Value ($ Billion)

22. Recommendations
22.1. Global Genito-Urinary Drugs Market In 2023- Growth Countries
22.2. Global Genito-Urinary Drugs Market In 2023- Growth Segments
22.3. Global Genito-Urinary Drugs Market In 2023- Growth Strategies

23. Appendix
23.1. NAICS Definitions Of Industry Covered In This Report
23.2. Abbreviations
23.3. Currencies
23.4. Research Inquiries
23.5. About the Publisher

24. Copyright And Disclaimer
Note: Product cover images may vary from those shown
3 of 5

Loading
LOADING...

4 of 5

FEATURED COMPANIES

  • Allergan Plc
  • Astellas Pharma Inc
  • Bayer AG
  • Daiichi Sankyo Company
  • Pfizer Inc
  • MORE
North America was the largest region in the global genito-urinary drugs market, accounting for 55% of the market in 2019. Asia Pacific was the second largest region accounting for 20% of the global genito-urinary drugs market. Africa was the smallest region in the global genito-urinary drugs market.

The launch of combination products for the treatment of urinary tract infections is an emerging trend in the genito-urinary disorder drugs market. Competitors in the market are developing combination drugs to fight multi-drug resistant bacteria and also expanding indications for existing drugs for the treatment of genito-urinary disorders. For instance, Merck Sharp & Dohme Corp. offers ZERBAXA, a combination drug of a novel cephalosporin and a beta-lactamase inhibitor used for the treatment of complicated urinary tract infections.

The genito-urinary drugs market consists of sales of genito-urinary drugs and related services by entities (organizations, sole traders and partnerships) that produce genito-urinary drugs to treat genito- urinary diseases. This industry includes establishments that produce infertility drugs, hormonal contraceptives, erectile dysfunction drugs and hormonal replacement drugs to treat infertility, infections and prevent pregnancy. It also consists of establishments which produce drugs for benign prostatic hypertrophy, drugs for urinary incontinence and overactive bladder, diuretics to treat urinary calculi, cystic kidney disease, Reno vascular diseases, glomerular disorders and other urinary disorders.

The global genito-urinary drugs market is expected to decline from $54.2 billion in 2019 to $43.8 billion in 2020 at a compound annual growth rate (CAGR) of -19.3%. The decline is mainly due to the disruption caused by the lockdown measure across various countries to contain COVID-19 spread. Currently there is less demand for genito-urinary drugs mainly as people are staying at home and are less likely to get exposed to factors that might cause genito-urinary infections, or other hormonal diseases caused by lifestyle changes or eating habits. The market is then expected to recover and grow at a CAGR of 4% from 2021 and reach $61.4 billion in 2023.
Note: Product cover images may vary from those shown
5 of 5
  • Daiichi Sankyo Company
  • Pfizer Inc
  • Bayer AG
  • Astellas Pharma Inc
  • Allergan Plc
Note: Product cover images may vary from those shown
6 of 5

Loading
LOADING...

Adroll
adroll